James M. Hinson

Corporate Officer/Principal presso Unicorn Pharma Consulting, Inc.

73 anni

Consumer Services

Health Technology

Profilo

James M.
Hinson is currently the owner of Unicorn Pharma Consulting, Inc. He was formerly the Chief Medical Officer at Aldagen, Inc. He holds a doctorate degree from Vanderbilt University and an undergraduate degree from the University of Missouri.

Posizioni attive di James M. Hinson

Società	Posizione	Inizio
Unicorn Pharma Consulting, Inc.	Corporate Officer/Principal	06/11/2009

Tutte le posizioni attive di James M. Hinson

Precedenti posizioni note di James M. Hinson

Società	Posizione	Fine
Aldagen, Inc. Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di James M. Hinson

Formazione di James M. Hinson

Vanderbilt University	Doctorate Degree
University of Missouri	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private